Behrman Capital acquires Atherotech
Behrman Capital, a private equity investment firm based in New York and San Francisco, has acquired Atherotech, a Birmingham, Alabama-based provider of cardiometabolic testing services that offers the VAP (Vertical Auto Profile) advanced lipid profile test. The transaction closed on December 23, 2010. The equity capital for the acquisition came

